ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $224,000 | -25.8% | 5,146 | -2.5% | 0.00% | -25.0% |
| Q3 2018 | $302,000 | +37.3% | 5,278 | +16.3% | 0.00% | +33.3% |
| Q2 2018 | $220,000 | +24.3% | 4,537 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $177,000 | -10.6% | 4,537 | -2.7% | 0.00% | 0.0% |
| Q4 2017 | $198,000 | -1.5% | 4,662 | -13.3% | 0.00% | 0.0% |
| Q3 2017 | $201,000 | +45.7% | 5,376 | +18.4% | 0.00% | +50.0% |
| Q2 2017 | $138,000 | +6.2% | 4,539 | -7.3% | 0.00% | 0.0% |
| Q1 2017 | $130,000 | -4.4% | 4,897 | -8.0% | 0.00% | -33.3% |
| Q4 2016 | $136,000 | -77.1% | 5,320 | -67.6% | 0.00% | -70.0% |
| Q3 2016 | $594,000 | +6.6% | 16,400 | 0.0% | 0.01% | -9.1% |
| Q2 2016 | $557,000 | +28.6% | 16,400 | 0.0% | 0.01% | +37.5% |
| Q1 2016 | $433,000 | -45.9% | 16,400 | 0.0% | 0.01% | -42.9% |
| Q4 2015 | $800,000 | +79.8% | 16,400 | -8.2% | 0.01% | +100.0% |
| Q3 2015 | $445,000 | -59.8% | 17,860 | -49.0% | 0.01% | -12.5% |
| Q2 2015 | $1,108,000 | +177.0% | 35,000 | +233.3% | 0.01% | +33.3% |
| Q1 2015 | $400,000 | -2.2% | 10,500 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $409,000 | +31.1% | 10,500 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $312,000 | – | 10,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |